Piper Jaffray Removes Immucor (BLUD) From Alpha List
More News related to BLUD
- Matrix USA Rating Changes 10/9
- Immucor (BLUD) Tops Q1 Earnings Views; Guides FY09
- Trading Radar for 10/1: Mosaic (MOS), Micron (MU), Actuant (ATU) Report; Auto/Truck Sales, ADP Employment Report, Construction Spending, Crude Inventories Due
- Immucor (BLUD) Announces Change in Board Members
- Susquehanna Raises Price Target on Immucor (BLUD) to $35
More News related to Analyst Comments
- After-Hours Movers 12/05: Actuate (ACTU) Up On Higher Tender Offer, RF Micro (RFMD) Lower on Guidance
- Trading Radar for 12/05: Big Lots (BIG), Flow Int'l (FLOW), Blyth (BTH) Report; Nonfarm Payrolls, Unemployment Rate, Consumer Credit Due
- Unusual 11 Mid-Day Movers 12/04: DXCM, TLB, PRKR, PSS Higher; CRUS, DMND, ITWO, DDMX Lower
- Notable Analyst Rating Changes 12/04: AMZN, YRCW, GPN, TRI Upgraded; DMND, DOX, FMCN, ISIL Downgraded
- Morning Movers 12/04: Merck (MRK) Lower On Guidance, Amazon.com (AMZN) Higher On Upgrade
Piper Jaffray removes Immucor (Nasdaq: BLUD) from Alpha List. Today, Piper Jaffray removed Immucor from its Alpha List because given Immucor's recent price appreciation it does not envision any new catalysts to drive the stock higher. However, Piper still is a fan of the long-term Immucor thesis behind Immucor.
Piper maintains its Buy rating on Immucor with a $39 price target.
Immucor, Inc. is the leading provider of automated instruments and reagents for blood typing and screening (immunohematology) to U.S. clinical labs.
Sign up at EasyStockAlerts.com & Make Money Today!
Related Categories
Analyst CommentsStocks Mentioned
-0.88Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
